Cancer Research UK logo.
SearchDonate
  • Search

A trial of nab-paclitaxel and gemcitabine for cancer of the pancreas that has spread (SIEGE)

Overview

Cancer types:

Pancreatic cancer

Status:

Results

Phase:

Phase 2

Details

This trial looked at 2 different ways of having nab-paclitaxel and gemcitabine chemotherapy for pancreatic cancer that has spread to another part of the body.

Recruitment start: 1 January 2014

Recruitment end: 23 March 2016

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Pippa Corrie

Supported by

Cambridge University Hospitals NHS Foundation Trust

Celgene

Experimental Cancer Medicine Centre (ECMC)

NIHR Clinical Research Network: Cancer

Cancer Research UK Cambridge Institute

Last reviewed: 10 June 2018

CRUK internal database number: 11741

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.